In The News
Competing Harvey Norman class actions get one more month to nut out deal
MinRes admits it should have disclosed related-party transactions
WiseTech Global faces class action by shareholders
Cbus dragged to court by ASIC for $20M in claim delays
Noumi privilege ruling could undermine ASIC investigations, Full Court told
Herbert Smith Freehills to merge with US firm Kramer Levin
Honda tells court it should be on the hook for $12M in spat with dealer
Ousted PwC partner settles defamation claim over tax leaks statements
Domestic airfares soared after collapse of regional carrier Rex, ACCC finds
Companies need to report basis for climate change statements, says ASIC
Please login to bookmarkClose

Drug maker Janssen will drop its long-running patent lawsuit against Alphapharm after the generic drug maker agreed to refrain from making products that allegedly infringe Janssen’s patents for its HIV drug Prezista.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au